In Vitro Method for Gut Absorption and Cytotoxicity

肠道吸收和细胞毒性的体外方法

基本信息

  • 批准号:
    6595805
  • 负责人:
  • 金额:
    $ 16.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-06-01 至 2006-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The Report of the International Workshop on In Vitro Methods for Assessing Acute Systemic Toxicity concludes that none of the available in vitro methods for assessing acute systemic toxicity have been evaluated adequately to replace the use of animals. In addition, the document recommends the development of a simple predictive system for gut absorption, which would optimize the ability of in vitro assays to predict in vivo LD50 values. Consequently, this proposal outlines a series of studies whose aim is to develop a cell culture technique with the potential to screen representative chemicals for their effect on gastrointestinal absorption (GIA) concomitantly with acute cytotoxicity. Effect of chemicals on GIA in vitro is determined using markers for paracellular permeability, including Lucifer yellow, FITC-dextran, [3H]-mannitol permeability, and transepithelial electrical resistance (TEER) measurements. Acute cytotoxicity is monitored with the MTT and NRU assays, recommended cytotoxic indicators for cell viability. Twenty chemical agents in the Registry of Cytotoxicity, suggested by the ICCVAM Guidance Document will be evaluated. Acute 3-hour and 24-hour exposures are performed with continuous Caco-2 monolayers. Dose-response curves are generated; 50% effective concentrations (EC50s) for GIA and 50% inhibitory concentrations (IC50s) for acute toxicity are extrapolated. Regression curves for both sets of data are calculated according to the Guidance Document. EC50s and IC50s are then compared to each other and to animal LD50s, human toxic and lethal concentrations, and human oral bioavailability data available for these chemicals. It is anticipated that a cell culture model that can simultaneously and systematically screen for acute toxicity and distinguish from the effect on GIA, may be used to predict starting doses for in vivo lethality studies and to improve the ability of in vitro cytotoxicity data to predict in vivo LD50 values.
描述(由申请人提供):评估急性全身毒性的体外方法国际研讨会报告得出结论,评估急性全身毒性的现有体外方法均未经过充分评估以取代动物试验。此外,该文件建议开发一种简单的肠道吸收预测系统,这将优化体外检测预测体内LD50值的能力。因此,本提案概述了一系列研究,其目的是开发一种细胞培养技术,以筛选具有代表性的化学物质对胃肠道吸收(GIA)伴随急性细胞毒性的影响。化学物质对体外GIA的影响是通过细胞旁渗透性标记物来确定的,包括路西法黄、fitc -葡聚糖、[3H]-甘露醇渗透性和经上皮电阻(TEER)测量。急性细胞毒性监测与MTT和NRU测定,推荐的细胞毒性指标的细胞活力。将对ICCVAM指导文件建议的细胞毒性登记中的20种化学制剂进行评估。急性3小时和24小时暴露于连续Caco-2单层。生成剂量-反应曲线;GIA的50%有效浓度(ec50)和急性毒性的50%抑制浓度(ic50)是外推的。根据指导文件计算两组数据的回归曲线。然后相互比较ec50和ic50,并与动物ld50、人类毒性和致死浓度以及这些化学品的人类口服生物利用度数据进行比较。可以预期,一个细胞培养模型可以同时和系统地筛选急性毒性和区分对GIA的影响,可用于预测体内致死研究的起始剂量,并提高体外细胞毒性数据预测体内LD50值的能力。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Validating and troubleshooting ocular in vitro toxicology tests.
Alternative methods for ocular toxicology testing: validation, applications and troubleshooting.
眼部毒理学测试的替代方法:验证、应用和故障排除。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANK A BARILE其他文献

FRANK A BARILE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANK A BARILE', 18)}}的其他基金

CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS
人类乳腺细胞的细胞和分子毒性
  • 批准号:
    6657552
  • 财政年份:
    2002
  • 资助金额:
    $ 16.19万
  • 项目类别:
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS
人类乳腺细胞的细胞和分子毒性
  • 批准号:
    6595210
  • 财政年份:
    2002
  • 资助金额:
    $ 16.19万
  • 项目类别:
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS
人类乳腺细胞的细胞和分子毒性
  • 批准号:
    6594602
  • 财政年份:
    2002
  • 资助金额:
    $ 16.19万
  • 项目类别:
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS
人类乳腺细胞的细胞和分子毒性
  • 批准号:
    6478828
  • 财政年份:
    2001
  • 资助金额:
    $ 16.19万
  • 项目类别:
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS
人类乳腺细胞的细胞和分子毒性
  • 批准号:
    6452775
  • 财政年份:
    2001
  • 资助金额:
    $ 16.19万
  • 项目类别:
CELLULAR AND MOLECULAR TOXICITY IN HUMAN MAMMARY CELLS
人类乳腺细胞的细胞和分子毒性
  • 批准号:
    6335946
  • 财政年份:
    1988
  • 资助金额:
    $ 16.19万
  • 项目类别:

相似海外基金

RII Track-4:NSF: In-vitro Cytotoxicity Assessment of Synthesized Quantum Dots for Enhanced Cell Imaging
RII Track-4:NSF:用于增强细胞成像的合成量子点的体外细胞毒性评估
  • 批准号:
    2327429
  • 财政年份:
    2024
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
Impact of Obesity on Chemotherapy-Induced Cytotoxicity: Immune Cells and Skeletal Muscle
肥胖对化疗引起的细胞毒性的影响:免疫细胞和骨骼肌
  • 批准号:
    10572695
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Cytotoxicity and function of incomplete proteins
不完整蛋白质的细胞毒性和功能
  • 批准号:
    10570685
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
Alpha-Synuclein aberrantly modifies the nanoscale distribution and function of ion channels to promote neuronal cytotoxicity
α-突触核蛋白异常地改变离子通道的纳米级分布和功能以促进神经元细胞毒性
  • 批准号:
    10635208
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
SBIR Phase I: Antibody Therapy that Targets Neoantigens in Acute Myeloid Leukemia via the Antibody Dependent Cell-mediated Cytotoxicity Mechanism of Natural Killer Cells
SBIR 第一期:通过抗体依赖性细胞介导的自然杀伤细胞的细胞毒性机制,针对急性髓性白血病新抗原的抗体疗法
  • 批准号:
    2246487
  • 财政年份:
    2023
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Standard Grant
NK Cell Cytotoxicity Against Cryptococcus neoformans in Persons with Advanced HIV and Cryptococcal Meningitis
NK 细胞对晚期 HIV 和隐球菌性脑膜炎患者的新型隐球菌的细胞毒性
  • 批准号:
    10543405
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Investigating the role of Cdk5 and p35 in natural killer cell cytotoxicity
研究 Cdk5 和 p35 在自然杀伤细胞细胞毒性中的作用
  • 批准号:
    10701749
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
抗体依赖性细胞毒性和 HIV-1 母婴传播
  • 批准号:
    10707299
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Co-Evolution Mechanisms of Pre-Cancer-Immune Interactions in Shaping Adaptive Cytotoxicity and Myeloid-Derived Suppression
形成适应性细胞毒性和骨髓源性抑制的癌前免疫相互作用的共同进化机制
  • 批准号:
    10518849
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
Optogenetic interrogation of TDP-43 cytotoxicity
TDP-43 细胞毒性的光遗传学研究
  • 批准号:
    22H02958
  • 财政年份:
    2022
  • 资助金额:
    $ 16.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了